Latest Consumer Staples News

Elixinol Wellness reported a 9.5% revenue increase in Q4 FY25 alongside a 30% reduction in operating costs, setting a clear path to profitability under fresh executive leadership.

Orora Limited has announced an ordinary unfranked dividend of AUD 0.05 per share for the six months ending December 2025, with a Dividend Reinvestment Plan available to shareholders.

Treasury Wine Estates has resolved its dispute with US distributor RNDC following RNDC’s exit from California, with a settlement impacting cash flow but supporting a positive earnings outlook for the first half of 2026.

A single exploration name blew the doors off the leaderboard, while two well-known uranium plays and a Nevada explorer sank hard. Behind the noise: deals got closer to completion, big raisings reset prices, and several “good news” gaps didn’t survive the week.

Synlait Milk Limited reveals a challenging first half of 2026 with significant losses expected, as it pivots its operations around Canterbury following the upcoming sale of its North Island assets.

Peak Processing Limited has raised $2.72 million through a discounted share placement to fund growth and operational improvements in its Canadian and US markets. Key directors are backing the raise, signalling confidence in the company’s strategy.

F.F.I. Holdings anticipates a modest decline in half-year profit, citing one-off lease expenses despite steady food operations.

Peak Processing Limited has completed a strategic rebrand and organisational restructure, securing new long-term manufacturing agreements and expanding product listings to strengthen its foothold in North America's regulated cannabis beverage markets.

Nuchev Limited reported a 19% decline in Q2 FY26 sales revenue, with steady retail performance in its Oli6® brand offset by a sharp drop in the Practitioner channel. The company remains debt-free and is advancing new product development to drive future growth.

Bubs Australia reports a 14% increase in half-year revenue, powered by a 47% jump in US sales, while other regions face challenges. The company remains optimistic about FDA approval and market recovery in H2 FY26.

Noumi Limited reported a 13.4% revenue increase in Q2 FY26 driven by strong growth in its Dairy and Nutritionals and Plant-based Milks segments, despite a $4.5 million operating cash outflow impacted by legal expenses. The company’s Milklab brand continues to gain traction both domestically and internationally.

The Calmer Co has posted a record $2.01 million in sales for Q2 FY26, propelled by a 9% increase in US revenue which now accounts for over half of the group’s total income. Strong retail and wholesale growth underpin the company’s expanding footprint in the natural relaxation market.